Clinical Assessment of Prostate Displacement and Planning Target Volume Margins for Stereotactic Body Radiotherapy of Prostate Cancer

Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2020.00539
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Stereotactic Body Radiotherapy for Prostate Cancer: Ready for Prime Time?

Journal of Radiation Oncology
OncologyRadiologyNuclear MedicineImaging
2012English

Seminal Vesicle Interfraction Displacement and Margins in Image Guided Radiotherapy for Prostate Cancer

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2012English

Stereotactic Body Radiotherapy for Low-Risk Prostate Cancer: Five-Year Outcomes

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2011English

Stereotactic Body Radiation Therapy for Prostate Cancer

Future Oncology
MedicineCancer ResearchOncology
2011English

Stereotactic Body Radiation Therapy for Oligometastatic Prostate Cancer

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

Use of Stereotactic Body Radiotherapy for Prostate Cancer in the United States From 2004 Through 2012

Cancer
Cancer ResearchOncology
2016English

Proctitis Following Stereotactic Body Radiation Therapy for Prostate Cancer

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2014English

Proctitis Following Stereotactic Body Radiation Therapy for Prostate Cancer

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2014English

Stereotactic Body Radiotherapy for Pancreatic Cancer

Hong Kong Journal of Radiology
Nuclear MedicineRadiologyImaging
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy